GABA in the mammalian suprachiasmatic nucleus and its role in diurnal rhythmicity

Nature
S WagnerY Yarom

Abstract

Mammals manifest circadian behaviour timed by an endogenous clock in the hypothalamic suprachiasmatic nucleus (SCN). Considerable progress has been made in identifying the molecular basis of the circadian clock, but the mechanisms by which it is translated into cyclic firing activity, high during the day and low at night, are still poorly understood. GABA (gamma-aminobutyric acid), a common inhibitory neurotransmitter in the central nervous system, is particularly densely distributed within the SCN, where it is located in the majority of neuronal somata and synaptic terminals. Using an in vitro brain-slice technique, we have now studied the effect of bath-applied GABA on adult SCN neurons at various times of the day. We find that GABA acts as an inhibitory neurotransmitter at night, decreasing the firing frequency; but during the day GABA acts as an excitatory neurotransmitter, increasing the firing frequency. We show that this dual effect, which is mediated by GABA(A) receptors, may be attributed to an oscillation in intracellular chloride concentration. A likely explanation is that the amplitude of the oscillation in firing rate, displayed by individual neurons, is amplified by the dual effect of GABA in the SCN's GABAergic n...Continue Reading

References

Dec 1, 1991·Trends in Neurosciences·E CherubiniY Ben-Ari
Dec 22, 1990·The Journal of Comparative Neurology·C Decavel, A N Van den Pol
Apr 1, 1993·The European Journal of Neuroscience·M CastelJ Storm-Mathisen
Jul 28, 1994·Nature·J CollingeJ G Jefferys
Feb 5, 1993·Neuroscience Letters·R Y Moore, J C Speh
Jul 1, 1996·Trends in Neurosciences·J P Estibeiro
Jan 1, 1996·Neuroscience·M BelenkyM Castel

❮ Previous
Next ❯

Citations

Feb 9, 2013·Psychopharmacology·Ryan Ting-A-KeeDerek van der Kooy
Sep 16, 2005·Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology·N Mrosovsky, S Hattar
Sep 22, 2009·Reviews in Endocrine & Metabolic Disorders·Michael C AntleBrooke D Rakai
Apr 25, 2012·Journal of Molecular Neuroscience : MN·Duk-Su KohLiangyi Chen
Dec 25, 2012·Archives of Pharmacal Research·Leeyup Chung
Jun 1, 2000·Clinical Transplantation·J HagelinJ Hau
Dec 8, 2004·Nature Neuroscience·Michael A LongRebecca D Burwell
Nov 21, 1998·The European Journal of Neuroscience·S Brückner, R L Hyson
Sep 6, 2000·The European Journal of Neuroscience·T ShirakawaK I Honma
Jan 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sung HanHoracio O de la Iglesia
Sep 30, 2004·Anatomical Science International·Chitoshi Takayama, Yoshiro Inoue
May 23, 1998·Annual Review of Pharmacology and Toxicology·E Costa
Feb 22, 2001·Annual Review of Physiology·S M Reppert, D R Weaver
Feb 20, 2004·Journal of Neurophysiology·Jason ItriChristopher S Colwell
Feb 17, 2006·Journal of Circadian Rhythms·Vallath Reghunandanan, Rajalaxmy Reghunandanan
Nov 7, 2002·Japanese Journal of Pharmacology·Yukiko NisikawaShigenori Watanabe
Mar 20, 2010·PLoS Computational Biology·Christina Vasalou, Michael A Henson
Jun 8, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yan-Gang SunMichael Beierlein
Jun 3, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ellena V McCarthyMichael N Nitabach
Jan 13, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Juhee HaamJeffrey G Tasker
May 23, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hee Joo ChoiYang In Kim
Jul 30, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Claudio Acuna-GoycoleaAnthony N van den Pol
Apr 12, 2013·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Kunihiko Obata
Jun 21, 2014·BioMed Research International·Javier AlamillaRaúl Aguilar-Roblero
Dec 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sara J AtonErik D Herzog
Nov 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kristopher T KahleRichard P Lifton
Aug 20, 2014·Current Psychiatry Reports·Dominic LandgrafDavid K Welsh
Mar 14, 2001·The Journal of Comparative Neurology·M A Belenky, G E Pickard
Jul 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·Sahar FarajniaStephan Michel
Jul 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jihwan MyungToru Takumi
Jul 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Daniel DeWoskinDaniel B Forger
Jul 3, 2004·Epilepsia·Jeeyoung OhSung Min Jung
May 19, 2004·The European Journal of Neuroscience·Heinrich S Gompf, Charles N Allen
Feb 27, 2004·The European Journal of Neuroscience·Roustem KhazipovGregory L Holmes
Mar 5, 2004·Expert Opinion on Therapeutic Targets·Jeffrey Sprouse
Oct 27, 1998·Chronobiology International·J D Miller
May 8, 2016·The Journal of Endocrinology·Jennifer A Evans

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.